<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01409057</url>
  </required_header>
  <id_info>
    <org_study_id>CTC-A 10-086 SEOPCAB</org_study_id>
    <nct_id>NCT01409057</nct_id>
  </id_info>
  <brief_title>Effect of Heart-lung-machine on Selenium Status of Cardiac Surgical Patients Undergoing Coronary Bypass Surgery</brief_title>
  <acronym>SEOPCAB</acronym>
  <official_title>SEOPCAB: Effect of Heart-lung-machine on Selenium Status of Cardiac Surgical Patients Undergoing Coronary Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since selenium has demonstrated significant characteristics for a series of biochemical&#xD;
      processes, for antioxidant activity and immune stimulation, this observational study should&#xD;
      represent the effect of heart-lung-machine on selenium status of cardiac surgical patients&#xD;
      undergoing coronary bypass surgery. It will be examined in (approximately 100) adult&#xD;
      patients, under which 50 patients are operated conventionally (meaning with the use of&#xD;
      heart-lung-machine). Another 50 patients are operated on beating heart without the use of&#xD;
      heart-lung-machine (OPCAB = &quot;off pump coronary artery bypass&quot;). The allocation of individual&#xD;
      patients in these two groups is done according to clinical criteria and is undertaken by the&#xD;
      operating surgeon.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To produce two comparable groups of patients, the characteristics are recorded using&#xD;
      EURO-Score; additionally the groups are &quot;matched&quot; (Matched-Pairs-Analysis).&#xD;
&#xD;
      All patients are operated by the same surgeon (senior physician Dr. A.K. Menon) under general&#xD;
      anaesthesia through median sternotomy with elective or urgent indications.&#xD;
&#xD;
      After induction of anaesthesia, within the first hour after admission to the Intensive Care&#xD;
      Unit (ICU) and every further morning in the ICU or Intermediate Care Station (IMC), 10ml&#xD;
      blood are removed by a central venous catheter, allowing to measure blood selenium levels in&#xD;
      whole blood by electrothermal atomic absorption spectrometry.&#xD;
&#xD;
      All blood draws will be held on vascular access, which is lying independently of the study&#xD;
      participation for surgery or for intensive care treatment. The blood samples will be stored&#xD;
      until completion of the study and its evaluation (up to 24 months) and are discarded&#xD;
      afterwards. All data collected are recorded on a documentation sheet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative serum levels of selenium</measure>
    <time_frame>48 hours</time_frame>
    <description>Perioperative serum levels of selenium in patients undergoing either conventional cardiac surgery with the use of cardiopulmonary-bypass (CPB) or without use of CPB on beating heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perioperative serum levels of macrophage migration inhibitory factor (MIF)</measure>
    <time_frame>48 hours</time_frame>
    <description>Perioperative serum levels of macrophage migration inhibitory factor (MIF)in patients undergoing either conventional cardiac surgery with the use of cardiopulmonary-bypass (CPB) or without use of CPB on beating heart.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Selenium Level</condition>
  <arm_group>
    <arm_group_label>No heart lung machine</arm_group_label>
    <description>Coronary-artery-disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart lung machine</arm_group_label>
    <description>Coronary artery disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 100 adult patients (male and female), capable of consenting, undergoing&#xD;
        cardiac surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Coronary-3-vessel-disease&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Age of 18 years or older&#xD;
&#xD;
          -  Study inclusion at the latest on the last evening before surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other serious cardiac diagnosis (i.e. aneurysm, valvular-diseases)&#xD;
&#xD;
          -  ischemic cardiomyopathy&#xD;
&#xD;
          -  Patients not capable of consenting&#xD;
&#xD;
          -  Pregnant or lactating women, women of child-bearing potential in whom pregnancy can&#xD;
             not be excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steffen Rex, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <study_first_submitted>August 2, 2011</study_first_submitted>
  <study_first_submitted_qc>August 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2011</study_first_posted>
  <last_update_submitted>December 11, 2012</last_update_submitted>
  <last_update_submitted_qc>December 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inflammation parameters</keyword>
  <keyword>Various blood values</keyword>
  <keyword>Clinical Outcome</keyword>
  <keyword>Residence in ICU/ Hospital</keyword>
  <keyword>SAPS-Score</keyword>
  <keyword>SOFA-Score</keyword>
  <keyword>Duration of artificial respiration</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

